Centrus Energy beats Q2 estimates, signs $900M HALEU deal
Centrus Energy Corp. delivered strong Q2 2026 results with adjusted EPS of $1.77 and revenue of $176.1 million, both significantly beating analyst expectations. Strategic wins include a $900M HALEU contract with the DOE and a total backlog of $4.5 billion.

*this image is generated using AI for illustrative purposes only.
Centrus Energy Corp. delivered a strong second-quarter performance in 2026, reporting adjusted earnings per share of $1.77, which significantly exceeded the analyst consensus estimate of $0.77 by 129.87 percent. The company’s quarterly sales reached $176.1 million, beating the consensus estimate of $148.764 million by 18.38 percent and marking a 13.98 percent rise from the $154.5 million recorded in the prior year period. This dual beat on top-line revenue and bottom-line profitability underscores robust operational execution and favorable market dynamics for the uranium enrichment provider.
The filing highlights that while GAAP net income decreased to $16.8 million from $28.9 million in Q2 2025, non-GAAP adjusted net income rose to $38.7 million from $34.5 million. The divergence between GAAP and adjusted metrics is primarily driven by $10.6 million in growth costs related to expansion projects and $17.7 million in stock-based compensation. Despite the GAAP decline, the substantial EPS surprise suggests improved operational efficiency or cost dynamics that were not fully anticipated by analysts in their conservative consensus models.
Financial Performance Metrics
| Metric | Actual | Estimate | Variance vs Estimate | Prior Year | YoY Change |
|---|---|---|---|---|---|
| Adjusted EPS | $1.77 | $0.77 | +129.87% | $1.59 | +11.32% |
| Quarterly Sales | $176.1 million | $148.764 million | +18.38% | $154.5 million | +13.98% |
| GAAP Net Income | $16.8 million | — | — | $28.9 million | -42% |
| Adj. Net Income | $38.7 million | — | — | $34.5 million | +12.17% |
Revenue from the Low-Enriched Uranium (LEU) segment was $153.4 million, up 22 percent year-over-year, driven by higher uranium revenue of $53.4 million. However, separative work units (SWU) revenue decreased by $25.7 million due to a 23 percent drop in volume sold, partially offset by a 3 percent increase in average SWU prices. The Technical Solutions segment saw revenue decline to $22.7 million from $28.8 million, largely due to reduced costs under the High-Assay, Low-Enriched Uranium (HALEU) Operation Contract with the Department of Energy.
Strategic Developments and Backlog
Beyond financial results, Centrus announced several key strategic milestones. The company signed a $900 million HALEU Enrichment award contract with the U.S. Department of Energy, strengthening its position in the nuclear fuel supply chain. Additionally, Centrus selected Geiger Brothers as the construction contractor for its major uranium enrichment plant expansion in Piketon, Ohio. The company also signed a first-of-a-kind, large-scale commercial HALEU supply agreement that potentially includes prepayments, further securing future cash flows.
These developments have contributed to a significant growth in contingent LEU and HALEU enrichment backlog, which now stands at $3.0 billion. Combined with its existing commitments, Centrus’s total backlog across both segments reached $4.5 billion as of June 30, 2026, extending visibility to 2040. The LEU segment backlog alone is approximately $3.7 billion, providing a stable foundation for future revenue generation.
What the Numbers Show
The most striking aspect of this quarter is the disparity between the modest 11.32 percent year-over-year growth in adjusted EPS and the massive 129.87 percent beat against estimates. Analysts had priced in a much weaker earnings outcome ($0.77) compared to the previous year’s $1.59, likely anticipating headwinds or margin compression. However, Centrus not only avoided this decline but achieved higher earnings than the prior year. This suggests that the market’s pessimistic outlook was overly cautious, and the company’s fundamental strength remains robust despite external challenges.
Furthermore, the 18.38 percent beat on sales estimates reinforces the notion of strong demand or successful execution in revenue-generating activities. When combined with the EPS beat, it points to a quarter where both volume/price drivers and cost management worked in the company’s favor. The significant investment in growth costs ($10.6 million) indicates that current profitability is being reinvested into future capacity, positioning Centrus to capitalize on long-term industry tailwinds.
How will the $900 million HALEU contract with the DOE impact Centrus's long-term revenue mix and dependency on government versus commercial clients?
What are the projected timelines and potential cost overruns for the Piketon, Ohio plant expansion given the selection of Geiger Brothers as the contractor?
Could the significant divergence between GAAP net income decline and adjusted EPS growth signal future margin pressure as expansion-related growth costs scale up?

































